Juan Virizuela Echaburu

Prediction of Serious Complications in Patients With Seemingly Stable Febrile Neutropenia: Validation of the Clinical Index of Stable Febrile Neutropenia in a Prospective Cohort of Patients From the FINITE Study

Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, Juan Virizuela Echaburu et al. · Journal of Clinical Oncology · 2015 · 161 citations · Full text

Medicine, Oncology, Cancer Epidemiology +12

Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial

Maria De Santis, Joan Palou Redorta, Hiroyuki Nishiyama et al. · The Lancet · 2025 · 47 citations · Full text

Medicine, Oncology, Urology +13

Intensive care in cancer patients in the age of immunotherapy and molecular therapies: Commitment of the SEOM-SEMICYUC

Alberto Carmona‐Bayonas, F. Gordo Vidal, Carmen Beato et al. · Medicina Intensiva · 2018 · 33 citations · Full text

Medicine, Immunology, Oncology +12

The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score

Paula Jiménez‐Fonseca, Juan Virizuela Echaburu, Manuel Sánchez Cánovas et al. · Clinical & Translational Oncology · 2017 · 14 citations

Pharmacy, Pathobiology, Immunopathology +4